{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-024540","form_type":"8-K","ticker":"MDAI","cik":"0001833498","company_name":"Spectral AI, Inc.","filed_at":"2025-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.164801+00:00","generated_at":"2026-05-24T16:31:04.287372+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Spectral AI DeepView System outperforms burn physicians in validation study; FDA submission planned mid-2025","bullets":["DeepView sensitivity 86.6% vs burn physicians 40.8% at image-wise level; pixel-wise 81.9% vs 38.8%.","Dice score 68.5% vs 39.2%; specificity 61.2% vs anticipated 36% (CJA 79.1%).","Study enrolled 164 patients (115 adult, 49 pediatric) across U.S. burn centers; one of largest U.S. burn trials.","Plans FDA De Novo submission by Q2 2025; targets clearance early 2026 and rapid commercialization."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-024540","json":"https://secwatch.observer/filing/0001213900-25-024540.json","markdown":"https://secwatch.observer/filing/0001213900-25-024540.md","text":"https://secwatch.observer/filing/0001213900-25-024540.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833498/000121390025024540/0001213900-25-024540-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833498/000121390025024540/ea0234647-8k_spectral.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T16:31:04.287372+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}